Ophthotech licenses experimental eye drug to Novartis

May 19, 2014 9:05 PM

17 0

Ophthotech's shares rose as much as 29 percent in trading after the bell.

The company said it could receive immediate payments, including upfront fees of $200 million and milestone payments of $130 million.

Read more

To category page